Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Becton Dickinson's revenue for the
three
months ended in Mar. 2026 was €4,078 Mil.
Its revenue for the trailing twelve months (TTM) ended in Mar. 2026 was €18,358 Mil.
Becton Dickinson's Revenue per Share for the
three
months ended in Mar. 2026 was €14.53.
Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was €64.28.
Good Sign:
Becton Dickinson & Co has shown predictable revenue and earnings growth.
During the past 12 months, the average Revenue per Share Growth Rate of Becton Dickinson was 8.10% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 4.90% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 4.70% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 3.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, Becton Dickinson's highest 3-Year average Revenue per Share Growth Rate was 14.40% per year. The lowest was 1.40% per year. And the median was 8.20% per year.
Becton Dickinson (FRA:BOX) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Becton Dickinson Revenue Related Terms
Becton Dickinson Revenue Historical Data
* Premium members only.
The historical data trend for Becton Dickinson's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Becton Dickinson's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Becton Dickinson Revenue vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Becton Dickinson's Revenue distribution charts can be found below:
* The bar in red indicates where Becton Dickinson's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €18,358 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Becton Dickinson (FRA:BOX) has a Revenue of €18,358 Mil as of Mar. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Becton Dickinson and its competitors.
Is Becton Dickinson's Revenue too high?
Becton Dickinson's current Revenue is €18,358 Mil. Overall, Becton Dickinson has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Becton Dickinson's Revenue compare to MDLN and RMD?
Becton Dickinson's Revenue of €18,358 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Medical Devices & Instruments company?
A good Revenue depends on the Medical Devices & Instruments industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Becton Dickinson and its competitors. Becton Dickinson's current Revenue is €18,358 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Becton Dickinson stock overvalued right now?
Based on GuruFocus' analysis, Becton Dickinson (FRA:BOX) is currently considered Modestly Undervalued. The stock's GF Value™ is €162.80, compared to a current price of €132.70 — trading 18.5% below its estimated fair value. The current Revenue is €18,358 Mil. Becton Dickinson's overall GF Score™ is 77/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Becton Dickinson (FRA:BOX), the current Revenue is €18,358 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Becton Dickinson (FRA:BOX) Overvalued in 2026?
Based on GuruFocus' analysis, Becton Dickinson stock appears to be undervalued.
The current stock price of €132.70 is trading 18.5% below its estimated GF Value™ of €162.80.
GuruFocus considers Becton Dickinson to be Modestly Undervalued.
Key valuation signals for FRA:BOX:
Revenue: €18,358 Mil
GF Value™: €162.80 vs. price of €132.70 (18.5% below fair value)
No single metric tells the full story. See the FRA:BOX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
77GF Score
Get the complete analysis for FRA:BOX
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:BOX has been successfully added to your 
